Weill Cornell Medicine
New York, 10021, United States
Location status: Recruiting
Location contact
Dolores Reynolds, BSN
CONTACT
Heather Glum, BSN, MPA
CONTACT
Jim Cheung, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05977049
The study hypothesis is that participants enrolled in a virtual Takotsubo support group will have significantly less anxiety at one year.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
New York, 10021, United States
Location status: Recruiting
Dolores Reynolds, BSN
CONTACT
Heather Glum, BSN, MPA
CONTACT
Jim Cheung, MD
PRINCIPAL_INVESTIGATOR
Takotsubo cardiomyopathy, sometimes termed Takotsubo syndrome and "broken heart syndrome," typically presents with symptoms remarkably similar to acute myocardial infarction (MI; heart attack): debilitating chest pain, shortness of breath, and a feeling of doom, among others. Takotsubo was first identified in 1990 in Japan. Most cases occur in older women. During the acute phase, the heart spontaneously undergoes "apical ballooning," changing shape to resemble a "takotsubo," a Japanese octopus trap. In approximately two-thirds of cases, Takotsubo is precipitated by an intense emotional or physical "trigger." Typically, the heart spontaneously reverts to its previous shape within about a month. Initially, it was thought that recurrence was rare. However, more recently, recurrences have been reported in 3-15% of cases. Many patients experience a variety of debilitating cardiac and psychological symptoms long after the initial presentation. There is no known way to prevent a recurrent event and patients are typically anxious about the possibility.
Since its inception as a diagnosis, one of the hallmarks of Takotsubo has been the absence of coronary artery plaque. In a surprising finding from 2019, a study of more than 1,000 Takotsubo patients undergoing coronary angiography reported that approximately 1/3 of patients had clinically significant plaque in their coronary arteries; 1/3 had evidence of sub-clinical atherosclerosis; and 1/3 had "clean coronaries," with no observable plaque. Hence, much needs to be learned about this syndrome that may affect as many as 5% of women who have been diagnosed with acute MI. Takotsubo is typically an emotionally challenging and life altering event. Strategies for primary and secondary prevention of coronary artery disease will be discussed in the virtual group sessions.
Currently, there is no specialized intervention for patients diagnosed with Takotsubo Syndrome at Weill Cornell Medical Center, either in hospital or after discharge.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will undergo virtual group therapy/education. Participants will meet once every other week (at minimum), for 1 - 1.5 hours (on average). The frequency and/or length of the support group sessions may be adjusted according to participants' needs.
Time frame: Baseline, One year
State Trait Anxiety Inventory (STAI):
Score of 20-39 = Low Anxiety; Score of 40-59 = Moderate Anxiety; Score of 60 - 80 = High Anxiety
Time frame: Baseline, One year
Patient Health Questionnaire depression scale (PHQ-8):
Score of 0-2 = No Depression; Score of 3-5 = Mild Depression; Score of 6-8 = Moderate Depression; Score of 9-12 = Severe Depression
Time frame: Baseline, One year
Kansas City Quality of Life Questionnaire (KCCQ):
Score of 0-24 = Very poor to poor quality of life; Score of 25-49 = Poor to fair quality of life; Score of 50-74 = Fair to good quality of life; Score of 75-100 = Good to excellent quality of life
Contact information is provided by the study sponsor or research team.
Dolores Reynolds, BSN
CONTACT
Heather Glum, BSN, MPA
CONTACT
Weill Medical College of Cornell University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03787810
Acute Coronary Syndrome, Cardiomyopathies
Gothenburg, Västra Götalandsregionen, Sweden
View Trial DetailsNCT06332859
Acute Coronary Syndrome, Cardiomyopathies
Bad Tatzmannsdorf, Burgenland, Austria
View Trial DetailsNCT05946772
Cardiomyopathies, Cardiovascular Diseases
Bad Nauheim, Germany
View Trial DetailsNCT04513054
Cardiomyopathies, Cardiovascular Diseases
Aberdeen, Aberdeenshire, United Kingdom
View Trial Details